ALS Limited (FRA:CP4)

Market Cap	7.48B +52.1%
Revenue (ttm)	1.80B +18.2%
Net Income	152.83M +4,272.6%
EPS	0.31 +4,374.6%
Shares Out	n/a
PE Ratio	48.97
Forward PE	30.54
Dividend	0.22 (1.52%)
Ex-Dividend Date	Nov 26, 2025

Volume	n/a
Average Volume	99
Open	14.30
Previous Close	14.50
Day's Range	14.30 - 14.30
52-Week Range	7.60 - 14.50
Beta	n/a
RSI	56.79
Earnings Date	May 26, 2026

About ALS Limited

ALS Limited engages in the provision of professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. It operates in two segments, Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production...

• Industry: Testing Laboratories
• Founded: 1863
• Employees: 20,515
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CP4

Financial Performance

In fiscal year 2025, ALS Limited's revenue was 3.00 billion, an increase of 21.85% compared to the previous year's 2.46 billion. Earnings were 256.20 million, an increase of 1886.05%.

Financial numbers in AUD